Singapore markets closed

Biolidics Limited (8YY.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.01200.0000 (0.00%)
At close: 05:04PM SGT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,315
1,315
2,489
2,314
8,907
Cost of revenue
594
594
1,326
1,831
5,468
Gross profit
721
721
1,163
483
3,439
Operating expenses
Research development
31
31
227
1,091
877.389
Total operating expenses
1,957
1,957
4,198
3,795
4,017
Operating income or loss
-1,236
-1,236
-3,035
-3,312
-577.881
Interest expense
113
113
168
208
127.248
Income before tax
-2,488
-2,488
-9,850
-6,040
-4,684
Income tax expense
0
0
-476
-56
-33.009
Income from continuing operations
-2,488
-2,488
-9,374
-5,984
-4,651
Net income
-2,488
-2,488
-9,374
-5,984
-4,651
Net income available to common shareholders
-2,488
-2,488
-9,374
-5,984
-4,651
Basic EPS
-0.02
-
-0.03
-0.02
-0.02
Diluted EPS
-0.02
-
-0.03
-0.02
-0.02
Basic average shares
488,785
-
281,687
264,992
272,040
Diluted average shares
488,785
-
281,687
265,207
272,705